Welcome to Cochlear ProNews, your professional resource for clinical updates, surgical insights and audiological advancements in implantable hearing solutions. Stay current with peer-reviewed articles, continuing education opportunities and the latest on Cochlear hearing implant technologies. Subscribe today to join our community of experts and stay connected to the latest in hearing healthcare.

Featured posts

Services & Support
by Christy LaPlante

Cochlear Named #1 Most Trustworthy Healthcare Company in the World for 2026

Newsweek’s World’s Most Trustworthy Companies 2026 Ranks Cochlear as Top Healthcare & Life Sciences Company LONE TREE, Colo. – Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been ranked No. 1 in the Health Care & Life Sciences industry by Newsweek in its World’s Most Trustworthy Companies 2026 rankings. This marks the second time in […]

Read More
Cochlear Implants
by Christy LaPlante

Cochlear® Nucleus® Nexa® System Named One of TIME’s Best Inventions of 2026

World’s first and only smart cochlear implant system1,* recognized among TIME’s most groundbreaking innovations of the year. LONE TREE, Colo. – Cochlear Limited (ASX: COH), a global leader in implantable hearing solutions, is excited to announce that the Cochlear® Nucleus® Nexa® System has been named one of TIME’s Best Inventions of 2026, recognizing its innovation in cochlear implant technology. The Nucleus Nexa […]

Read More
Bone Conduction
by Christy LaPlante

Cochlear Introduces the New Osia® 3 Sound Processor

[LONE TREE, CO] – July 13, 2026: Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announces FDA clearance of the new Cochlear® Osia® 3 Sound Processor, the newest advancement of the award-winning Osia System.‡ Cochlear’s bone conduction hearing solutions are designed to improve hearing outcomes for children and adults with conductive hearing loss, mixed hearing loss and single-sided […]

Read More

All posts

→
Cochlear logo - white

©Cochlear Limited 2026. All rights reserved. For a full list of Cochlear’s trademarks, please visit our Terms of Use page. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

 

This blog is intended to serve as a resource for clinicians to help keep up to date with current clinical literature and is intended for professionals only. Clinical literature is based on research, which may include the experimental use of new or currently available products and technologies. Therefore, literature presented on this blog may represent use of Cochlear products that does not align with the intended use or indications approved by regulatory bodies, also known as off-label use. Cochlear does not condone any off-label use of its products, and it is not Cochlear’s intent to promote off-label use by providing this blog as a resource for healthcare professionals.

 

This material is intended for health professionals. If you are a consumer, please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always read the instructions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.

 

Cochlear ProNews is monitored Monday through Friday, excluding some holidays. Questions and inquiries submitted over the weekends or holidays may see a delay in response. For immediate assistance please contact us directly. You are solely responsible for your interactions with other members of our Websites. Cochlear reserves the right, but has no obligation, to monitor disputes or communications between you and other members of our Websites. For a full list of Cochlear’s terms of use, click here.